You are here

  • Home
  • Archive
  • Volume 76, Issue 4
  • Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)

Article metrics

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)

 

Online download statistics by month:

Online download statistics by month: October 2016 to September 2023

AbstractFullPdf
Oct 20161925157
Nov 20161112628576
Dec 2016279280239
Jan 2017199220250
Feb 201732219164
Mar 201720522281
Apr 20178390186
May 20173266125
Jun 201738172113
Jul 2017183179101
Aug 201713212860
Sep 201713612451
Oct 201715013969
Nov 201710510434
Dec 201711411229
Jan 201818517549
Feb 201813012049
Mar 201815315236
Apr 201812412834
May 201813713858
Jun 201812812052
Jul 201813914068
Aug 201815315368
Sep 201811911560
Oct 201816216266
Nov 201814915667
Dec 2018737433
Jan 2019868840
Feb 201911312667
Mar 20199910177
Apr 201910710668
May 2019807848
Jun 2019727130
Jul 2019979552
Aug 2019918771
Sep 2019777350
Oct 20191039963
Nov 201910710762
Dec 201912812747
Jan 2020908861
Feb 2020888255
Mar 202010710266
Apr 2020989676
May 202011311282
Jun 2020787446
Jul 2020928982
Aug 2020716974
Sep 20201059675
Oct 202010810776
Nov 20201129960
Dec 2020938852
Jan 2021686742
Feb 2021828258
Mar 2021808048
Apr 2021636335
May 2021747345
Jun 2021605944
Jul 2021505045
Aug 2021585836
Sep 2021626127
Oct 2021525231
Nov 2021686847
Dec 2021535226
Jan 2022556424
Feb 2022636645
Mar 202210410863
Apr 202212012333
May 202210510541
Jun 2022737431
Jul 2022706431
Aug 2022928830
Sep 2022636241
Oct 2022717226
Nov 2022666527
Dec 2022373111
Jan 2023655814
Feb 2023888316
Mar 202311311234
Apr 2023484929
May 2023545226
Jun 2023504913
Jul 2023444115
Aug 2023736125
Sep 2023646217
Total895896815531